Trial Site Detail

 

Drug:
Imatinib
Trial:
Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (ImadGist)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Institut de Cancérologie de Lorraine

     
Vandoeuvre-les-Nancy , Meurthe et Moselle 54511
France

 

Principal Investigator:
 Maria Rios, Dr
Contact:
 Maria RIOS, Dr +33 3 83 59 85 66 m.rios@nancy.unicancer.fr
Activation Status of this Site:
 Active
Notes about this Site:
Institut de Cancérologie de Lorraine Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.